Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: Thymosin Alpha-1 + LL-37 evidence and protocol review
Also known as: TA-1 + LL-37
This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.
Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.
Thymosin Alpha-1 + LL-37 combines Thymosin Alpha-1 + LL-37 into a single research protocol. Each component is independently studied; this entry summarizes the individual evidence base for the combination, since no unified safety/efficacy dataset covers the mixed formulation unless noted below. Thymosin Alpha-1: 28-amino-acid thymic peptide (thymalfasin), first isolated 1977; extensive research in viral infections, sepsis, and cancer immunotherapy adjunct use, approved in 35+ countries but not FDA-approved in the US. LL-37: Human cathelicidin antimicrobial peptide (hCAP-18 C-terminal fragment); broad-spectrum antimicrobial activity plus cellular effects including chemotaxis, angiogenesis, and epithelial wound repair. This is a community-stacking combination assembled from two independently studied compounds rather than a pharmaceutical sponsor's dedicated fixed-dose combination program - no dedicated human combination trial exists for this exact pairing as of this writing.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Evidence for individual components does not validate the exact mixed formulation. Component amounts, ratios, compatibility, sterility, and stability must be documented.
Supplementary research context only. Not medical advice or a treatment recommendation.
Best-effort summary of forum/Reddit discussion. This is anecdotal community commentary, not a scientific source, and does not count toward this record's verification status. Do not treat it as established fact or medical guidance.
Community discussion of Thymosin Alpha-1 is active and generally positive for immune support, including long-COVID-related use; LL-37 specifically has less community discussion, and no threads address the combination directly. Anecdotal, not clinically verified for this specific combination.
Community write-up describing Thymosin Alpha-1's immune-support effects and positioning it as a candidate for a "yearly protocol"; informational/summary post from an enthusiastic user perspective.
User with long-term long-COVID symptoms reports substantial improvement (including hair regrowth) while using Thymosin Alpha-1, noting the effect reversed after stopping; single self-reported account, not corroborated by clinical data.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.